President & CEO
Doug joined Shockwave as Chief Executive Officer in May 2017 to lead the company into US commercialization and international expansion. This followed his most recent tenure as the CEO and a Director of HeartWare, a leader in the LVAD market. He managed the organization from a pre-commercial phase to over $250M in sales until it was acquired by Medtronic in August of 2016 for $1.1B.
Prior to HeartWare, Doug held other executive and leadership positions at Boston Scientific, including President of the Vascular Surgery Division, member of Boston Sci’s Operating Committee and Vice President of Business Development where he was responsible for more than 70 transactions, many in the arena of coronary and peripheral interventions.
Doug earned an MBA from Northeastern University and a BA in Economics from Lafayette College.